The Glymphatic System – A New Player  in Alzheimer Disease?
Upcoming SlideShare
Loading in...5
×
 

The Glymphatic System – A New Player in Alzheimer Disease?

on

  • 3,206 views

Presentation made January 8, 2014 at the AlzForum live webinar: http://www.alzforum.org/webinars/neurovascular-underpinnings-alzheimers-dementia-0

Presentation made January 8, 2014 at the AlzForum live webinar: http://www.alzforum.org/webinars/neurovascular-underpinnings-alzheimers-dementia-0

Statistics

Views

Total Views
3,206
Views on SlideShare
578
Embed Views
2,628

Actions

Likes
0
Downloads
31
Comments
0

5 Embeds 2,628

http://www.alzforum.org 2468
http://alzforum.org 151
http://brf.local 6
http://devlocal.alzforum.com 2
https://www.linkedin.com 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Astrocytes areelectrically non-excitable and have traditionally been regarded as the supportive cell of the brain. The glia field has made tremendous progress over the past decade and we have developed a much more sophisticated view on the multi-faceted function of astrocytes that is so than just 15 years. We know know that astrocytes can mudulatesynapric transmission and play important role in complex cognitive functions such as working memory and sleep – with several of the key studies done here at Penn. One concern is that essential the new data on organization, development, differentiation, and function have been generated in rodent. Even worse, essentially all our understanding of astrocytic calcium signaling and gliotransmissionhas been collected in mice or rat pups.
  • The influx of tracer can also be studied by injecting the tracer in CM follwoe by perfusion of the brain at various time points thereafter. We have here injected a small red tracer anda larger green tracer and harvested the brain just 5 min later. Most of the larger penetrating arteries are otline and it is clear that the red smaller tracer
  • The influx of tracer can also be studied by injecting the tracer in CM follwoe by perfusion of the brain at various time points thereafter. We have here injected a small red tracer anda larger green tracer and harvested the brain just 5 min later. Most of the larger penetrating arteries are otline and it is clear that the red smaller tracer
  • The influx of tracer can also be studied by injecting the tracer in CM follwoe by perfusion of the brain at various time points thereafter. We have here injected a small red tracer anda larger green tracer and harvested the brain just 5 min later. Most of the larger penetrating arteries are otline and it is clear that the red smaller tracer
  • The influx of tracer can also be studied by injecting the tracer in CM follwoe by perfusion of the brain at various time points thereafter. We have here injected a small red tracer anda larger green tracer and harvested the brain just 5 min later. Most of the larger penetrating arteries are otline and it is clear that the red smaller tracer
  • Despite decades of effort, one of the biggest mysteries in biology is still why sleep is restorative and conversely why lack of sleep impairs brain functions

The Glymphatic System – A New Player  in Alzheimer Disease? The Glymphatic System – A New Player in Alzheimer Disease? Presentation Transcript

  • The Glymphatic System – A New Player in Alzheimer Disease? Maiken Nedergaard Univ. of Rochester
  • CNS is a metabolic highly active organ
  • CNS is a metabolic highly active organ • ~ 2% of the body weight (3 pounds)
  • CNS is a metabolic highly active organ • ~ 2% of the body weight (3 pounds) • ~ 15% of the cardiac output • ~ 20% of total body O2 consumption • ~ 25% of total body glucose consumption
  • CNS is a metabolic highly active organ • ~ 2% of the body weight (3 pounds) • ~ 15% of the cardiac output • ~ 20% of total body O2 consumption • ~ 25% of total body glucose consumption All biological activity is associated with production of waste products
  • CNS is a metabolic highly active organ • ~ 2% of the body weight (3 pounds) • ~ 15% of the cardiac output • ~ 20% of total body O2 consumption • ~ 25% of total body glucose consumption All biological activity is associated with production of waste products
  • CNS is a metabolic highly active organ • ~ 2% of the body weight (3 pounds) • ~ 15% of the cardiac output • ~ 20% of total body O2 consumption • ~ 25% of total body glucose consumption All biological activity is associated with production of waste products Does the brain really recycle all cellular waste products?
  • CNS is lacking a lymphatic system
  • CNS is lacking a lymphatic system elephantiasis
  • CSF has been proposed to act as a sink for waste B/Y?
  • CSF has been proposed to act as a sink for waste Waste diffusion? B/Y?
  • Pulsatility may drive CSF into brain CSF pulsation B/Y?
  • In vivo imaging of CSF tracers
  • In vivo imaging of CSF tracers Vasculature CSF tracer 180 µm below the surface
  • Ex vivo imaging of CSF tracers Texasred dextran FITC dextran 5 min
  • Ex vivo imaging of CSF tracers Texasred dextran FITC dextran 5 min
  • CSF tracers rapidly enter brain along the vasculature Texasred dextran FITC dextran 5 min 5 min
  • CSF tracers rapidly enter brain along the vasculature Astrocytic Vascular Endfeet AQP4 GFAP DAPI
  • Does AQP4Brain AquaporinsCSF influx? promote Brain Bulk Flow Astrocytic Vascular Endfeet Wild Type AQP4 GFAP DAPI Tracer DAPI 30 min
  • Does AQP4Brain AquaporinsCSF influx? promote Brain Bulk Flow AQP4 KO Astrocytic Vascular Endfeet Wild Type AQP4 GFAP DAPI Tracer DAPI 30 min
  • Novel macroscopic clearance path in CNS Science, 2013
  • Glymphatic system Jeff Iliff, 2012
  • Brain Bulk Flow Does AQP4Brain Aquaporins in amyloid clearance? play a role
  • Brain Bulk Flow Does AQP4Brain Aquaporins in amyloid clearance? play a role 125IAmyloid 1-40
  • Brain Bulk Flow Does AQP4Brain Aquaporins in amyloid clearance? play a role 125IAmyloid 1-40
  • Brain Bulk Flow AQP4 deletionAquaporins amyloid clearance Brain reduces 125IAmyloid 1-40
  • Diagnostic test of glymphatic function based on MRI JCI, 2013
  • Diagnostic test of glymphatic function based on MRI When is the glymphatic most active? JCI, 2013
  • Does arousal regulate glymphatic activity?
  • Does arousal regulate glymphatic activity?
  • Does arousal regulate glymphatic activity?
  • Does arousal regulate glymphatic activity?
  • In vivo imaging of tracer influx in the awake state Cascade blue IV CSF tracer
  • In vivo imaging of tracer influx in K/X anesthesia Cascade blue IV CSF tracer
  • In vivo imaging of tracer influx in sleep vs awake CSF tracer CSF tracer
  • In vivo imaging of tracer influx in awake vs K/X anesthesia 200 µm 200 µm 200 µm CSF tracer - awake CSF tracer - anesthesia
  • In vivo imaging of tracer influx in sleep vs awake C S F 200 µm 200 µm 200 µm t r a c eCSF tracer - awake r CSF tracer - sleep
  • In vivo imaging of tracer influx in sleep vs awake vs anesthesia
  • In vivo imaging of tracer influx in awake vs following exposure to norepinephrine receptor antagonists
  • In vivo imaging of tracer influx in awake and following exposure to norepinephrine receptor antagonists 200 µm 200 µm 200 µm
  • In vivo imaging of tracer influx in awake and following exposure to norepinephrine receptor antagonists 200 µm 200 µm 200 µm
  • In vivo imaging of tracer influx in awake and following exposure to norepinephrine receptor antagonists 200 µm 200 µm 200 µm
  • Is glymphatic clearance reduced in the awake state?
  • Glymphatic clearance is reduced in the awake state Amyloid *; p<0.01, awake compared with sleep and KX, n = 77
  • Diseases associated with sleep disorders • • • • Alzheimer's disease (AD) Parkinson's disease (PD) Huntington's disease Progressive supranuclear palsy • • • • Hydrocephalus Encephalitis Multiple sclerosis Traumatic and ischemic injury
  • Conclusion: •The glymphatic system share many functions with the system lymphatic system •AQP4 deletion suppress clearance of beta-amyloid by 60% •Glymphatic clearance peaks during sleep or anesthesia, when norepinephrine is low Implications: •Macroscopic glymphatic clearance may play a role in neurodegenerative diseases. Is AQP4 a new therapeutic target? •Sleep promotes removal of biological waste in CNS •Glymphatic influx of CSF can also be used to deliver drugs to CNS
  • Jeff Iliff Lulu Xie Minghuan Wang Ditte Lovatt Nathan Smith Karl Kasischke Hongyi Kang Nancy Oberheim Martha Windrem Xioaning Han Takahiro Takano Lane Bekar Arnulfo Torres Qiwu Xu Marisa Cotrina Marie Simard Xiaohai Wang Jane Lin Guofeng Tian Nanhong Liu NINDS/NIH, Dana Foundation, Adelson, Keck Foundation, Mathers Foundation and NY State Collaborators: Helene Benveniste Alcino Silva Charles Nicholson Gerald Dienel Jian Kang Klaus Willecke Bruce Ransom Steve Goldman